Biokin Pharmaceutical is a biomedical enterprise focused on the global biomedical frontier, committed to addressing unmet clinical needs. It possesses full-series drug research and development capabilities encompassing small-molecule chemical drugs, large-molecule biologics, and ADC drugs. With integrated advantages ranging from intermediates, active pharmaceutical ingredients (APIs), to formulations, it covers the entire lifecycle from "R&D to Production to Marketing", offering comprehensive commercialization capabilities.

Nationally Certified"National High-tech Enterprise", "The National Enterprise Technology Center","Exemplar IP Generating Entity"and Provincially Certified "Technological Innovation Exemplar Entity by .Sichuan Province
Received national, provincial, and city levelgrants for development efforts

As a global MNC focused on innovative tumor treatments, we possess a powerful R&D platform for sustainable innovation, an efficient operational platform, and numerous gold-standard drugs. We have earned widespread praise, long-term trust from doctors and patients, and widespread respect in the industry.

Mission ：We strive for breakthrough innovations to achieve breakthrough therapies, aspiring to continuously bring more survival opportunities to every cancer patient worldwide until the end of their natural lifespan.